Biochip Array Technology is a novel proprietary technology from Randox Biosciences. Biochip Array Technology (BAT) is an exquisite precision in multiplex testing platform allowing the simultaneous quantitative or qualitative detection of a wide range of analytes from a single sample. It provides a unique platform for assessment of biological samples in a rapid, accurate and easy to use format.
Biochip Array Technology and the Evidence analyser are a solution which produces a complete patient profile, providing exceptional time, resource and cost savings.
BAT uniquely offers immunoassay diagnostic testing for simultaneous multi-analyte Biomarker detection. After addition of a single patient sample to the biochip, analytes present in the sample bind to the specific Biochip bound ligands. The degree of binding is determined using a chemiluminescent light source and quantified using a Charge Coupled Device (CCD) camera and imaging system.
Each biochip has 25 Discrete Test Regions (DTR’s) which each detect a different Biomarker. This means that 23 tests can be carried out simultaneously with two additional DTR’s reserved for internal quality control, a unique Biochip Array Technology feature.
Randox Biosciences offer three biochip analysers, the Evidence, Evidence Investigator, Evidence MultiStat and the Evidence Evolution. Each is suited to a different clinical setting to suit your testing need.